Antares Pharma (ATRS) Receves Minutes from Type A Meeting with FDA in Connection with XYOSTED NDA
Tweet Send to a Friend
Antares Pharma, Inc. (NASDAQ: ATRS) (the Company) today announced that the official minutes from the Type A meeting with the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
